• Mon news: Ventyx gets boost from Sanofi. PhRMA IRA legal challenge gets new life. AZ breast cancer drug disappoints. Teva’s once-monthly schizophrenia med. AZ gets FDA approval for first self-administered flu vaccine. See more on our front page

SixPeaks, a new obesity biotech, starts up with an option to sell to AstraZeneca

Quote
cafead

cafead

Administrator
Staff member
  • cafead   May 22, 2024 at 11:52: AM
via The pharma participated in the startup’s Series A round, has committed to invest another $80 million, and could acquire the company within the next two years.

article source
 

<



Similar threads

cafead
Sanofi scoops negotiation rights to Ventyx obesity, Parkinson’s candidate for $27M
Replies
0
Views
1
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Novo obesity prospect linked to ‘mild to moderate neuropsychiatric side effects’ in phase 2
Replies
0
Views
28
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
EU regulator backs use of Novo&#039;s Wegovy for obesity-related heart condition
Replies
0
Views
4
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Obesity pill race heats up as Novo, Roche and Terns share data
Replies
0
Views
45
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
‘The trajectory is encouraging.’ Roche hopes obesity drug will show 25% weight loss one day
Replies
1
Views
72
Pharma/Biotech Companies - In the News
anonymous
Top Bottom
Back
Quote